Key Takeaways California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-packThe state has invested $100 million to lower insulin costsThe effort could save patients $2,000 to ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.

Sanofi SNY announced up to a 78% cut in the list price of its most popular insulin, Lantus, following the likes of rival Novo Nordisk NVO and Eli Lilly LLY. Similar to Lilly, Sanofi also said it is ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

Novo Nordisk said Tuesday it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...

After years of political pressure, insulin prices are finally starting to drop, and some New Yorkers are paying less at pharmacies as a result. Yet not everyone with diabetes is benefiting from these ...

Novo Nordisk said Tuesday it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical ...

Novo Nordisk plans to slash the U.S. list prices for several of its insulin drugs by as much as 75%, the company said on Tuesday. The move follows Eli Lilly's announcement earlier this month that it ...